
Vijaya Diagnostic Centre reported strong financial growth for the quarter ending March 2026. Standalone net sales rose 29.04% year-on-year to Rs 206.27 crore, with net profit increasing 58.98% to Rs 52.65 crore. Consolidated net sales grew 26.63% to Rs 219.38 crore, and net profit rose 38.37% to Rs 47.93 crore. EBITDA and earnings per share also showed significant year-on-year gains. Shares closed at Rs 1,208.10 on May 6, 2026.
The articles focus solely on Vijaya Diagnostic Centre's financial performance without political commentary or framing. Coverage is limited to business metrics and stock market data, representing a neutral corporate perspective without political viewpoints or partisan framing.
The tone across the articles is positive, emphasizing significant year-on-year increases in sales, profit, EBITDA, and earnings per share. The coverage highlights financial growth and market performance without criticism or negative aspects, reflecting an overall optimistic sentiment.
Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.
| Source | Their headline | Bias | Sentiment |
|---|---|---|---|
| moneycontrol | Vijaya Diagnost Consolidated March 2026 Net Sales at Rs 219.38 crore, up 26.63 Y-o-Y- Moneycontrol.com | Center | Positive |
| moneycontrol | Vijaya Diagnost Standalone March 2026 Net Sales at Rs 206.27 crore, up 29.04 Y-o-Y- Moneycontrol.com | Center | Positive |
moneycontrol broke this story on 8 May, 06:21 am. Other outlets followed.
Well-covered story — coverage matches public importance.
Institutions and figures named across source coverage.
Select a news story to see related coverage from other media outlets.